Identification of potential inhibitors of protein-protein interaction useful to fight against Ebola and other highly pathogenic viruses

Despite the efforts to develop new treatments against Ebola virus (EBOV) there is currently no antiviral drug licensed to treat patients with Ebola virus disease (EVD). Therefore, there is still an urgent need to find new drugs to fight against EBOV. In order to do this, a virtual screening was done...

Descripción completa

Detalles Bibliográficos
Autores principales: Lasala, Fátima, García-Rubia, Alfonso, Requena, Carlos, Galindo, Inmaculada, Cuesta-Geijo, Miguel Angel, García-Dorival, Isabel, Bueno, Paula, Labiod, Nuria, Luczkowiak, Joanna, Martinez, Ana, Campillo, Nuria E., Alonso, Covadonga, Delgado, Rafael, Gil, Carmen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2021
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833471/
https://www.ncbi.nlm.nih.gov/pubmed/33428961
http://dx.doi.org/10.1016/j.antiviral.2021.105011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833471/
https://www.ncbi.nlm.nih.gov/pubmed/33428961
http://dx.doi.org/10.1016/j.antiviral.2021.105011

Ejemplares similares